Vault EDC combined with IRT software will help improve data quality
and speed study execution for the most complex clinical trials
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva
Systems (NYSE: VEEV) today announced it will partner with leading
interactive response technology (IRT) vendors to provide advanced
randomization and trial supply management capabilities with Veeva
Vault EDC. Veeva is bringing together a modern EDC cloud application
with best-in-class randomization and trial supply software to help the
life sciences industry improve data quality and accelerate execution
when managing complex clinical trials. Veeva’s open partnership approach
will allow customers to use Vault EDC with the IRT solution that best
meets their needs.
Veeva will work with an ecosystem of highly specialized solutions like
4G Clinical, Almac Group, Bracket, IDDI, and YPrime to support
sophisticated, adaptive trial designs. Customers will be able to assign
patient treatments and supply investigator sites, while ensuring that
accurate data flows seamlessly with Vault EDC to streamline trial design
and execution. Veeva will also offer stratified randomization as a core
capability in Vault EDC.
“Veeva is committed to customer success and making it easier for
companies to use Vault EDC with the software of their choice to manage
randomization and their global supply chains,” said Richard Young, vice
president of Vault EDC.
“Combining a modern EDC application with advanced randomization and
supply management will help us ensure we have quality data output for
our most sophisticated trials,” said Kelly Ritch, vice president,
clinical trial operations, IND 2 Results. “The ability for EDC and IRT
solutions to work together is critical to implementing complex study
designs with greater speed and efficiency.”
Veeva Vault EDC is a flexible, modern cloud application that helps life
sciences companies easily design studies, manage amendments, and improve
the speed and quality of data collection in clinical trials. Vault EDC
is part of the Veeva
Vault Clinical Suite, which also includes Vault
eSource, Vault
CTMS, Vault
eTMF, Vault
Study Startup, and Vault
SiteExchange, to streamline clinical operations and clinical data
management.
Market Response to Veeva’s Approach
At a recent Veeva partner event, leading IRT vendors shared their
thoughts on the opportunity to combine their advanced randomization and
supply management capabilities with Vault EDC:
“4G Clinical is excited about Veeva Systems’ partner approach with Veeva
Vault EDC and our Prancer RTSM solution,” said 4G CEO Dave Kelleher. “As
the need for speed and flexibility for complex trials increases, it is
critical to align with other organizations that support our commitment
to bring crucial medicines to those who need them faster.”
“Almac is proud to collaborate with Veeva on this innovative open
partnership approach to offer clients greater flexibility and data
quality,” said George Tiger, vice president of global business
development, Almac Group. “We look forward to working closely with the
Veeva team going forward.”
“Integrating with EDC and other eClinical systems is an essential
component of how Bracket designed our clinical IRT platform,” said Jim
Primerano, GM, eClinical, at Bracket. “We are excited about the
opportunity to work with Veeva to give their customers a comprehensive
solution for their clinical trials.”
“The seamless integration of modern EDC and IRT solutions is key for the
successful conduct and quality delivery of complex clinical trials,”
said Damien Tremolet, CEO of IDDI.
“It’s exciting when two companies with significant complimentary
expertise come together to make things easier for the customers we
serve,” said Shawn Blackburn, CEO of YPrime.
Additional Information
For more on Veeva Vault EDC, visit: veeva.com/VaultEDC
Stay updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 550 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2017. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
® 2017 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo
are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other
registered and unregistered trademarks.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171101005692/en/
Source: Veeva Systems